17β-estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis
Authors
abstract
previous studies have demonstrated the potential of monotherapy with either mesenchymal stem cells (mscs) or estrogen in autoimmune and cuprizone models of multiple sclerosis (ms). the aim of this study was to examine the effects of co-administration of 17β-estradiol (e2) and adipose-derived mesenchymal stem cells (adscs) on remyelination of corpus callosum axons in a cuprizone model of ms. forty eight male c57bl/6 mice were fed cuprizone (0.2%) for 6 weeks. at day 0 after cuprizone removal, animals were randomly divided into four groups. the e2 monotherapy, adscs monotherapy, e2/adscs combined therapy and vehicle control. some mice of the same age were fed with their normal diet to serve as healthy control group. e2 pellets, designed to release 5.0 mg e2 over 10 days, were implanted subcutaneously. 106 pkh26 labeled adscs were transplanted into lateral tail. the extent of demyelination, remyelination, and cell type's composition of host brain were examined at 10 days post-transplantation in the body of the corpus callosum. transplanted cells migrated to the corpus callosum injury. histological examination revealed efficacy of intravenous adscs transplantation in remyelination of mouse cuprizone model of ms can be significantly enhanced by e2 administration. flow cytometry showed that the mean percentages of expression of iba-1, olig2 and o4 were significantly increased in e2/adscs combined therapy in comparison with adscs monotherapy. in conclusion, the findings of this study revealed that e2 administration enhanced efficacy of intravenous adscs transplantation in remyelination of corpus callosum axons in mouse cuprizone model of ms.
similar resources
17β-Estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
Previous studies have demonstrated the potential of monotherapy with either mesenchymal stem cells (MSCs) or estrogen in autoimmune and cuprizone models of multiple sclerosis (MS). The aim of this study was to examine the effects of co-administration of 17β-estradiol (E2) and adipose-derived mesenchymal stem cells (ADSCs) on remyelination of corpus callosum axons in a cuprizone model of MS. For...
full textComparison of the effects of 17β- estradiol treated and untreated mesenchymal stem cells on ameliorating animal model of multiple sclerosis
Objective(s): The current investigation was undertaken to evaluate the effects of 17β- estradiol (17β-ED) on the potential of the mesenchymal stem cells (MSCs) for modulation of immunity responses in an animal model of multiple sclerosis (MS).Materials and Methods: After isolation of MSCs, cells were cultured in presence of 100 nM 17β-ED for 24 hr. Modeling of experimental autoimmune encephalom...
full textpromotion of remyelination by adipose mesenchymal stem cell transplantation in a cuprizone model of multiple sclerosis
objective: multiple sclerosis (ms) is an immune-mediated demyelinating disease of the central nervous system (cns). stem cell transplantation is a new therapeutic approach for demyelinating diseases such as ms which may promote remyelination. in this study, we evaluate the remyelinating potential of adipose mesenchymal stem cells (adscs) and their effect on neural cell composition in the corpus...
full textEvaluating the Viability of Adipose Tissue-derived Mesenchymal Stem Cells in Diabetic Culture Media Model
Introduction: In diabetes mellitus, stem cells are exposed to inappropriate conditions such as an increase of glucose in extracellular space, oxidative stress, and deprivation from growth factors (following ischemia). This study was aimed to evaluate the effect of these conditions on stem cells. Methods: Stem cells were isolated from subcutaneous adipose tissue of rats. The cells were maintaine...
full textPromotion of Remyelination by Adipose Mesenchymal Stem Cell Transplantation in A Cuprizone Model of Multiple Sclerosis
OBJECTIVE Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system (CNS). Stem cell transplantation is a new therapeutic approach for demyelinating diseases such as MS which may promote remyelination. In this study, we evaluate the remyelinating potential of adipose mesenchymal stem cells (ADSCs) and their effect on neural cell composition in the corpus ...
full textMy Resources
Save resource for easier access later
Journal title:
acta medica iranicaجلد ۵۰، شماره ۱۲، صفحات ۷۸۹-۷۹۷
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023